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Abstract 2,4-diamino-6-hydroxy-pyrimidine (DAHP), an inhih- 
itor of GTP cyclohydrolase I, blocks the synthesis of tetrahydro- 
biopterin (BH,), which is a known cofactor of inducible nitric 
oxide synthase (iNOS). Previously, DAHP was shown to sup- 
press the production of nitric oxide by cytokine-activated fibro- 
blasts, smooth muscle cells or endothelial cells which could be 
attributed to its function as a cofactor antagonist. Here, we 
demonstrate that in interferon-y-activated murine peritoneal 
macrophages DAHP suppresses the expression of iNOS mRNA 
and protein in a BH,-independent manner and, thus, acts by a 
novel mechanism. 
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1. Introduction 
Nitric oxide (NO) is now recognized as a potent inter- and 
intracellular effector molecule which is implicated in a great 
variety of physiological and pathological processes including 
the regulation of vascular tone, the secretion of hormones, the 
contractility of cardiomyocytes, the killing of microbes and 
tumor cells, the induction of immunosuppression and the de- 
struction of tissue in autoimmune processes. Inducible nitric 
oxide synthase (INOS), the enzyme responsible for high output- 
production of NO from t_-arginine and molecular oxygen in 
cytokine-activated cells (reviewed in [14]), requires tetrahydro- 
biopterin (BH,) as a cofactor for activity [5,6]. In mouse fibro- 
blasts, murine brain endothelial cells, rat vascular smooth mus- 
cle cells and the mouse macrophage cell line RAW264.7, the 
induction of NO release by interferon-y (IFN-y), tumor necro- 
sis factor-a and/or lipopolysaccharide (LPS) is paralleled by an 
enhanced formation of BH, and an up-regulation of GTP- 
*Corresponding author. Fax: (49) (9131) 852573. 
Abbreviations: BH,, 2-amino-4-hydroxy-6-(L-erythro- 1,2-dihydroxy- 
propyl)-5,6,7&tetrahydropteridin; DAHP, 2,4-diamino-6-hydroxy-py- 
rimidine; iNOS. inducible nitric oxide svnthase (NOS whose activitv is 
independent of exogenous calmodulin-and elevation of intracellular 
[Ca”] above the level in resting cells; IFN-r, interferon-y; LPS, bacte- 
rial lipopolysaccharide; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5- 
diphenyl tetrazolium bromide; NO, nitric oxide; L-Sep, L-sepiapterin; 
TGF-b, transforming growth factorj3. 
cyclohydrolase I [7-151, the rate-limiting enzyme for the de 
novo-synthesis of BH, (reviewed in [ 16,171). Conversely, 2,4- 
diamino-6-hydroxy-pyrimidine (DAHP), an inhibitor of GTP- 
cyclohydrolase I, was found to suppress the accumulation of 
NO; in these cells [8, 10-141. In all these studies the decreased 
generation of NO after DAHP treatment was attributed to a 
lack of BH, and subsequent reduced activity of iNOS. More 
recent studies suggest that BH4, in addition to its presumed 
activity as a redox-active cofactor, is also required for the 
dimerization and stability of the iNOS protein [ 188201. Deacti- 
vating cytokines which cause suppression of iNOS [21, 221 
might therefore act via inhibition of BH, synthesis. In order to 
test the hypothesis that a lack of BH, directly affects the expres- 
sion of iNOS protein, we utilized DAHP as an inhibitor of 
biopterin synthesis and investigated its effect on iNOS in pri- 
mary murine macrophages. Unexpectedly, we found that 
DAHP down-regulates the expression of iNOS protein and 
mRNA in a BH,-independent manner. 
2. Experimental 
2.1. Materials 
Recombinant murine IFN-y (batch M3RD48; protein concentration 
1.0 mg/ml; specific activity 5.2 x lo6 U/mg; LPS content < 10 pg/ml) 
was a kind gift of Dr. G. Adolf (Ernst Boehringer Institut fur Arznei- 
mittelforschung, Vienna, Austria). The hemisulfate salt of 2,4-diamino- 
6-hydroxy-pyrimidine (DAHP; lot 13H3437), 3-[4,5-dimethylthiazol-2- 
yl]-2,5-diphenyl tetrazolium bromide (MTT) and LPS 0111: B4 were 
obtained from Sigma Chemie (Deisenhofen, Germany). L-sepiapterin 
and (6R-) tetrahydrobiopterin were purchased from Dr. Schircks Co. 
(Jona, Switzerland). 
2.2. Macrophage cultures 
Thioglycolate-elicited peritoneal macrophages were prepared from 
female CD1 mice (X-12 weeks old: Charles River Breeding Laborato- 
ries, Sulzfeld, Germany). The cells were cultured with RPM1 1640 
medium plus 5% fetal bovine serum (Sigma) (final LPS-content: < 10 
pg/ml as determined by a calorimetric limulus amebocyte lysate assay; 
Whittaker Bioproducts, Walkersville, MD) in 96-well plates (2 x 10’ 
macrophages in 100 pl), 24-well plates ( lo6 macrophages/well in a vol- 
ume of 500 pl), or 78 cm’ tissue culture dishes (12-20 x 106/dish; 500 
~1 medium per IO6 macrophages) at 37 “C in 5% C02/95% air and 
enriched for macrophages by a l-2 h adherence step as described 
[22,23]. Subsequently, macrophages were stimulated with IFN-y 
(20 &ml) ? LPS (20 &ml) in the absence or presence of DAHP 
(& L-sepiapterin). 
2.3. MTT transformation assay for assessment of cellular toxicity 
Macrophage monolayers were stimulated in 96-well plates with 
IFN-y (20 @ml) in the presence or absence of 10 mM DAHP. After 
48 h MTT was added to a final concentration of 5 &ml for 4 h. The 
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Fig. 1. Effect of DAHP on NO production by macrophages stimulated 
with IFN-y + LPS (20 ng/ml each) for 48 h. NO; accumulation in 
unstimulated cultures was 0.003 nmoV2 x 10’ macrophages. One of 
4 similar experiments. 
resulting formazan crystals were dissolved by the addition of 10% 
SDS/O.Ol-N HCl for 16 h and the absorbance was read at a test wave- 
length of 570 nm (reference wave length 630 nm) in a MR5000 plate 
reader (Dynatech, Denkendorf, Germany) as described in detail else- 
where [24]. 
2.4. Determination of NO; accumulation in culture supernatants. iNOS 
enzyme assay, SDS-PAGE, and Western blot analysis 
For measurement of NO; accumulation in culture supernatants as an 
indicator of NO production, the preparation of macrophage lysates, 
determination of iNOS enzyme activity and detection of iNOS protein 
by SDS-PAGE and Western blot with a polyclonal anti-iNOS antibody, 
we exactly followed previously published methods [22]. 
2.5. Determination of intracellular pteridines and GTP cyclohydrolase I 
activity in macrophage extracts 
Macrophage monolayers were washed with PBS, lysed in sterile dis- 
tilled water, flash frozen in liquid nitrogen and kept at -70°C until 
oxidation. Lysates were centrifuged at 10,000 x g and the supernatants 
were immediately used for measurement of intracellular levels of total 
biopterin and BH, as well as for GTP cyclohydrolase I activity assays. 
Pteridine measurements and enzyme assays were carried out as detailed 
previously [7]. Briefly, lysate samples were oxidized at acidic or alkaline 
pH and biopterin was detected by HPLC with fluorescent detection. 
The amount of tetrahydrobiopterin was calculated from the difference 
of total biopterin (acidic oxidation) to 7&dihydrobiopterin plus biop- 
terin (alkaline oxidation). GTP cyclohydrolase I activity was deter- 
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mined using 2 mM GTP as a substrate in the presence of 5 mM EDTA. 
After treatment with 8 U/ml of alkaline phosphatase (from calf intes- 
tine, 3077 U/mg protein; Serva, Heidelberg, Germany) and oxidation 
with iodine at acidic pH, the resulting neopterin was quantified by 
HPLC. 
2.6. Determination of extracellular pteridines 
Supernatants from macrophage monolayers were flash frozen in liq- 
uid nitrogen and assayed for total biopterin after iodine oxidation in 
acidic media, using HPLC with fluorescent detection as detailed else- 
where [7]. 
2.7. RNA preparation, Northern blot and hybridization 
Total RNA was isolated from macrophage monolayers by a rapid 
guanidinium isothiocyanate method [25], electrophoresed and trans- 
ferred to reinforced nitrocellulose membranes, which were UV- 
crosslinked, prehybridized, hybridized and exposed exactly as previ- 
ously described [22,23]. The probe specific for murine iNOS was an 
814-bp EcoRIIAccI fragment of iNOS cDNA clone B2 [26], which was 
random-primer labelled with 50&i of [a-‘*P]dCTP (3,000 Ci/mmol, 10 
mCi/ml; NEN DuPont, Bad Homburg, Germany) according to the 
manufacturer’s protocol (Boehringer, Mannheim, Germany). Mem- 
branes were subsequently hybridized with a random-primer radiola- 
belled mouse jI-actin DNA fragment (corresponding to bp 62-635 of 
the murine /_I-actin sequence) or an oligoprobe for murine 16s mito- 
chondrial rRNA [27] which was 5’ end-radiolabelled as described [22]. 
3. Results 
3.1. DAHP inhibits the accumulation of NO, in the supernatant 
of IFN-y activated primary murine macrophages 
When macrophages were stimulated with IFN-y in the 
presence of 5 or 10 mM DAHP, the accumulation of NO; 
in the culture supernatants was reduced by 75 f 2.5% 
(mean f S.E.M., IZ = 33). The concentration of DAHP causing 
50% inhibition (IC,,) was 3.4 f 0.5 mM (mean + S.E.M., n = 9) 
and, thus, similar to values reported for other cell types [8,11]. 
A representative dose-curve experiment is shown in Fig. 1. In 
contrast, induction of NO production by IFN-y (20 ng/ml) plus 
LPS (20 ng/ml) was only weakly inhibited by 10 mM DAHP 
(34 + 3.5% in 5 experiments). If DAHP was added at 24 h after 
initiation of IFN-y stimulation, it failed to inhibit and slightly 
enhanced further accumulation of NO; during a subsequent 
2448 h culture period (not shown). 
In accordance with previous studies [8,11,14], DAHP at the 
concentrations used did not decrease the viability of the macro- 
phages as indicated by three different sets of experimental evi- 
dence. First, the total yield of protein from DAHP-treated 
Table 1 
Effect of DAHP (f~-sepiapterin) on iNOS enzyme activity and the BH, content of macrophages activated by IFN-y (20 @ml) for 48 h (Exp. 1) 
or 35 h (Exn. 2) \ 1  /  
Exp. IFNy DAHP L-Sepiapterin iNOS activity Total biopterin Total biopterin 
(mM) 01M) (pmol/mg/min) (nmol/l (pmol/mg $oli,g 
suoernatant) homogenate) homogenate) 
1 - - 0 42.9 485 454 
+ - _ 545.1 102.9 438 416 
+ 10 _ 140.8 29.4 23 18 
+ 2 _ 312.3 29.4 41 37 
+ 0.2 _ 347.1 41.2 265 238 
2 _ - _ 0 38.1 393 369 
+ - 484.2 73.2 481 442 
+ 10 - 31.2 19.5 35 22 
+ 10 100 93.5 1,524.4 3,472 2,986 
Duplicate cultures were processed for the determination of iNOS activity or intra- and extracellular biopterin levels. 
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Fig. 2. Western blot analysis (20 pg lysate/lane) of the expression of 
iNOS protein in macrophages activated by IFN-r f LPS (20 ng/ml 
each) for 48 h. Panel A: DAHP (0.2-10 mM) was added together with 
the stimulus. Panel B: DAHP (10 mM) was added together with or 24 h 
after the stimulus. The enzyme activities of the lysates in panel A are 
shown in Table 1 (Exp. 1). (+) Position of the typical iNOS doublet 
(ca. 130 kDa). One of 14 (panel A) or 3 (panel B) similar experiments. 
macrophages was not significantly different from 48 h control 
cultures (428 + 43 pug/ml vs. 456 f 42 pg/ml, n = 17). Second, 
DAHP treatment did not affect mitochondrial activity as deter- 
mined by the transformation of MTT into formazan (OD,,, nm 
was 0.338 & 0.008 in DAHP-treated vs. 0.358 ? 0.01 in control 
cultures after IFN-y stimulation; one of 3 experiments). Fi- 
nally, expression of j?-actin mRNA (not shown) or 16s ribo- 
somal RNA (see below) was unaltered in the presence of 
DAHP. 
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3.2. DAHP leads to a decrease of the intra- and extracelhdar 
biopterin levels 
As a known competitive inhibitor of GTP-cyclohydrolase I 
[28] DAHP was previously shown to diminish the concentra- 
tions of intracellular biopterin in fibroblasts, vascular smooth 
muscle cells and the RAW 264.7 cell line [S, 11,131. We found 
that DAHP also concentration-dependently depleted IFN-y 
stimulated primary macrophages of intracellular BH, and total 
biopterin (Table 1). In the presence of 10 mM DAHP, the 
intracellular BH, content was reduced by 95 ? 0.4% 
(mean f S.E.M. of 4 experiments) compared to untreated con- 
trols. Furthermore, the IFN-y induced up-regulation of ex- 
tracellular biopterin levels was antagonized by DAHP. Thus, 
the suppressive effect of DAHP on macrophage NO production 
is paralleled by decreased formation of BH,. 
3.3. BH,-independent down-regulation of iNOS enzyme activity 
and protein expression by DAHP 
In order to further analyse the functional relationship be- 
tween DAHP-mediated NO suppression and BH,-depletion, we 
determined the activity of iNOS in lysates from DAHP-treated 
and control macrophages. Despite the presence of excess 
amounts of BH, (4 PM) in the assay system [22] the enzymatic 
activity was strikingly reduced in lysates from macrophages 
stimulated with IFN-y in the presence of DAHP (Table 1). The 
mean (? S.E.M.) suppression of enzyme activity afforded by 10 
mM DAHP was 82 ? 4.3% (n = 11). This result indicated that 
DAHP-mediated suppression of iNOS activity is not due to a 
lack of intracellular BH,. 
Subsequent Western blot analysis revealed that DAHP 
down-regulates the IFN-y-induced expression of iNOS protein 
at 18-66 h of stimulation to a similar extent as transforming 
growth factor-p (TGF-/3; [22]) (Fig. 2A and data not shown). 
In contrast, DAHP caused only weak suppression of iNOS 
enzyme activity (35 ? 3.8%; mean + S.E.M. of 3 experiments) 
and protein expression if the macrophages were stimulated with 
IFN-I/ plus LPS instead of IFN-I/ alone (Fig. 2B). When DAHP 
was added to the macrophages at 24 h of stimulation, i.e. after 
full induction of iNOS, no suppression of iNOS protein (Fig. 
2B) or activity (not shown) was observed during the following 
24-30 h of culture. 
Finally, and most importantly, the suppressive effect of 
DAHP on NO; accumulation, iNOS enzyme activity and pro- 
tein expression was not reversed by L-sepiapterin (Fig. 3A,B; 
Table 1). Once taken up by cells, L-sepiapterin yields BH, via 
a sepiapterin reductase-dihydrofolate reductase salvage path- 
way [ 161. Although the intra- and extracellular biopterin levels 
rose dramatically in the presence of L-sepiapterin (Table l), the 
suppression of iNOS enzyme activity achieved by DAHP only 
slightly decreased from 87 f 6.7% to 75 ? 4% (mean t S.E.M.) 
in a series of 4 experiments. 
3.4. DAHP down-regulates the expression of iNOS mRNA 
Whereas the results of the Western blot analysis are amena- 
ble to the hypothesis that DAHP down-regulates the expression 
of iNOS protein via depletion of intracellular BH,, the inability 
of L-sepiapterin to counteract the effect of DAHP strongly 
argues against this possibility. We therefore tested whether 
DAHP affects the expression of iNOS mRNA. As illustrated 
in Fig. 4A, DAHP decreased the levels of iNOS mRNA 
in IFN-y activated macrophages. The extent of suppression 
12 
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L-S~P (@I) 
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Fig. 3. L-sepiapterin is unable to reverse the down-regulation of iNOS protein by DAHP. A: Macrophages were stimulated with IFN-y (20 
ng/ml) k DAHP (10 mM) for 72 h (Exp. 1) or 66 h (Exp. 2). Gels used for the Western blot were loaded with 15 pg (Exp. 1) or 20 fig protein per 
lane (Exp. 2). B: NO; accumulation in the supernatant of the cultures of Exp. 1. One of 5 similar experiments. 
appeared to be comparable at 24, 48 and 72 h of stimulation 
(Fig. 4 A,B). These results demonstrate that the marked sup- 
pression of iNOS protein after DAHP treatment results from 
a strongly reduced iNOS mRNA expression. 
4. Discussion 
Previous studies have demonstrated that high-output genera- 
tion of NO by iNOS and synthesis of BH, are coinduced in 
mouse fibroblasts [S], murine brain endothelial cells [lo], and 
rat vascular smooth muscle cells [ll]. Conversely, DAHP re- 
duced both the intracellular BH, content and the accumulation 
of NO; in the respective cultures. As the DAHP effect was at 
least partially reversed by precursors of BH, (e.g. L-se- 
piapterin), it was concluded that DAHP downregulates the 
production of NO via reduced formation of BH, [8, 10, 111. The 
experiments presented here demonstrate that the mechanism of 
NO suppression by DAHP is different in primary murine mac- 
rophages. Besides NO; measurements we performed iNOS en- 
zyme activity assays, Western and Northern blot analysis, 
which revealed that DAHP down-regulates iNOS mRNA and 
protein expression in addition to its suppression of BH, synthe- 
sis. The effect of DAHP on iNOS was dependent on the stim- 
ulus inasmuch as it was largely abolished in the presence of 
LPS, but it was not reversed by L-sepiapterin and, thus, inde- 
pendent of intracellular BH, levels. 
In the past DAHP was shown to inhibit cytokine-induced 
NO; accumulation in a number of different macrophage popu- 
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Fig. 4. Northern blot analysis of the effect of DAHP on the expression 
of iNOS mRNA in macrophages stimulated with (panel A) IFN- 
y + DAHP (0.2-10 mM) for 48 h or with (panel B) IFN-y f DAHP (10 
mM) for 24 or 72 h. Blots (10 pg (A) or 5 pg (B) of total RNA/lane) 
were exposed to X-ray film for 48 h (rRNA) or 4 days (INOS). 
lations, but no detailed studies on its mechanism of action were 
provided [12-141. The results reported, however, are compati- 
ble with ours. In IFN-y activated rat alveolar macrophages 
L-sepiapterin also failed to reverse the effect of DAHP and 
turned out to be inhibitory by itself [12]. The NO production 
of RAW 264.7 cells stimulated with IFN-y plus LPS was not 
suppressed by coincubation with DAHP, and even after pre- 
treatment of the cells with DAHP the inhibition was weak [13]. 
Finally, DAHP down-regulated the release of NO by IFN-y/ 
LPS-activated murine peritoneal exudate macrophages, but 
data which would allow to ascribe the effect to inhibition of 
BH, synthesis were not presented [14]. 
The question arises why DAHP apparently suppresses iNOS 
by two different mechanisms depending on the cell type. Prolif- 
erating cells such as fibroblasts, endothelial cells or vascular 
smooth muscle cells have very low or even undetectable basal 
biopterin levels [8,10,11]. Upon cytokine stimulation, their bi- 
opterin content rises quite dramatically, which is a prerequisite 
for the induction of iNOS activity. In such a situation, inhibi- 
tion of BH, synthesis by DAHP will suffice to down-regulate 
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the release of NO, and addition of an exogenous BH, source 
(e.g. L-sepiapterin) restores the production of NO, even if iNOS 
mRNA and protein were somewhat reduced by DAHP. At 
least in rat vascular smooth muscle cells the inhibitory effect 
of DAHP was observed in the absence of altered iNOS mRNA 
levels, and the cytosol of treated cells even exhibited a 5-fold 
higher activity of iNOS if tested in the presence of exogenous 
BH, [29]. In macrophages, in contrast, basal BH, levels are 
already high and cytokine induction of iNOS is paralleled by 
only marginal increases of the intracellular BH, content [ 1,131 
(Table 1). Unless the cells are completely depleted of BH, [13], 
the activity of iNOS will primarily depend on the iNOS mRNA 
and protein levels. In this case, the inhibitory effect of DAHP 
results from reduced iNOS mRNA expression rather than from 
decreased intracellular BH, concentrations, which makes it 
largely insensitive to L-sepiapterin. 
So far we can only speculate on the mechanism by which 
DAHP down-regulates iNOS mRNA expression. It is conceiv- 
able that the inhibition of GTP-cyclohydrolase I by DAHP 
leads to accumulation of intracellular GTP. This might affect 
the activity of G-proteins and, thus, alter intracellular signalling 
[30,31] In fact, there is recent evidence that G-proteins are 
involved in the induction of iNOS [32]. Alternatively, it is pos- 
sible that DAHP down-regulates the activity of a so far uniden- 
tified enzyme involved in the activationltranslocation of tran- 
scription factors or the transcription process itself. Finally, 
DAHP is a pyrimidine and might therefore directly interfere 
with mRNA synthesis. 
In summary, we have identified primary murine macroph- 
ages as a cell type in which the suppression of NO production 
by DAHP is due to a decreased expression of iNOS protein and 
mRNA. Such a mechanism should be taken into consideration 
in future studies whenever DAHP is used for analysing the BH, 
dependency of iNOS in a certain type of cell. 
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